// App-Quantinova.ai

41 : DELAYED REDUCTION IN CYSTATIN C-BASED GFR AFTER PCI IS A PREDICTOR OF ADVERSE OUTCOMES IN PATIENTS WITH PRESERVED RENAL FUNCTION

Researchers

Presenter

  • H.B. Park

Principal Investigators

  • D.H. Shin

  • J.S. Kim

  • B.K. Kim

  • D. Choi

  • M.K. Hong

  • Y. Jang

Medical Centers

  • Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Renal disease

  • Stroke

Biomarkers

  • Creatinine

  • Cystatin C

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved